Balyasny Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,709
| Closed | -$173K | – | 3012 |
|
|
2024
Q1 | $173K | Sell |
32,709
-48,943
| -60% | -$264K | ﹤0.01% | 2441 |
|
|
2023
Q4 | $354K | Buy |
+81,652
| New | +$271K | ﹤0.01% | 2095 |
|
|
2022
Q4 | – | Sell |
-13,851
| Closed | -$33K | – | 3160 |
|
|
2022
Q3 | $33K | Buy |
+13,851
| New | +$40.4K | ﹤0.01% | 2523 |
|
|
2019
Q3 | – | Sell |
-94,836
| Closed | -$1.21M | – | 1498 |
|
|
2019
Q2 | $1.21M | Buy |
94,836
+40,655
| +75% | +$936K | 0.01% | 1027 |
|
|
2019
Q1 | $2.1M | Buy |
54,181
+13,774
| +34% | +$421K | 0.02% | 804 |
|
|
2018
Q4 | $822K | Sell |
40,407
-399,962
| -91% | -$12M | 0.01% | 958 |
|
|
2018
Q3 | $20.2M | Buy |
440,369
+277,994
| +171% | +$13.4M | 0.11% | 300 |
|
|
2018
Q2 | $9.6M | Sell |
162,375
-102,595
| -39% | -$5.95M | 0.05% | 501 |
|
|
2018
Q1 | $18M | Buy |
264,970
+210,097
| +383% | +$15.7M | 0.09% | 351 |
|
|
2017
Q4 | $5.42M | Sell |
54,873
-132,886
| -71% | -$14.9M | 0.02% | 831 |
|
|
2017
Q3 | $22.5M | Buy |
+187,759
| New | +$17.5M | 0.1% | 297 |
|
|
2016
Q4 | – | Sell |
-124,028
| Closed | -$8.32M | – | 1474 |
|
|
2016
Q3 | $8.32M | Buy |
+124,028
| New | +$6.27M | 0.05% | 422 |
|
|
2016
Q2 | – | Sell |
-33,713
| Closed | -$990K | – | 1415 |
|
|
2016
Q1 | $990K | Sell |
33,713
-229,573
| -87% | -$10.4M | 0.01% | 772 |
|
|
2015
Q4 | $20.6M | Buy |
+263,286
| New | +$20.7M | 0.16% | 201 |
|
|
2014
Q3 | – | Sell |
-32,087
| Closed | -$2.12M | – | 894 |
|
|
2014
Q2 | $2.12M | Buy |
+32,087
| New | +$2.28M | 0.04% | 523 |
|
|
2013
Q4 | – | Sell |
-83,234
| Closed | -$4.47M | – | 632 |
|
|
2013
Q3 | $4.47M | Buy |
83,234
+47,967
| +136% | +$2.59M | 0.08% | 362 |
|
|
2013
Q2 | $1.56M | Buy |
+35,267
| New | +$1.24M | 0.04% | 455 |
|
Other funds holding PBYI
FLSM
GPP
EP
ACM
